These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 29845881)
1. A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model. Thom G; Tian MM; Hatcher JP; Rodrigo N; Burrell M; Gurrell I; Vitalis TZ; Abraham T; Jefferies WA; Webster CI; Gabathuler R J Cereb Blood Flow Metab; 2019 Oct; 39(10):2074-2088. PubMed ID: 29845881 [TBL] [Abstract][Full Text] [Related]
2. Directing adenovirus across the blood-brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model. Tang Y; Han T; Everts M; Zhu ZB; Gillespie GY; Curiel DT; Wu H Gene Ther; 2007 Mar; 14(6):523-32. PubMed ID: 17167498 [TBL] [Abstract][Full Text] [Related]
3. Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system. Thom G; Hatcher J; Hearn A; Paterson J; Rodrigo N; Beljean A; Gurrell I; Webster C MAbs; 2018; 10(2):304-314. PubMed ID: 29182455 [TBL] [Abstract][Full Text] [Related]
4. A novel IL-1RA-PEP fusion protein alleviates blood-brain barrier disruption after ischemia-reperfusion in male rats. Zhang DD; Jin C; Zhang YT; Gan XD; Zou MJ; Wang YY; Fu WL; Xu T; Xing WW; Xia WR; Xu DG J Neuroinflammation; 2018 Jan; 15(1):16. PubMed ID: 29334965 [TBL] [Abstract][Full Text] [Related]
5. Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles. Kuo YC; Wang IH J Drug Target; 2016 Aug; 24(7):645-54. PubMed ID: 26768307 [TBL] [Abstract][Full Text] [Related]
6. Complex of human Melanotransferrin and SC57.32 Fab fragment reveals novel interdomain arrangement with ferric N-lobe and open C-lobe. Hayashi K; Longenecker KL; Liu YL; Faust B; Prashar A; Hampl J; Stoll V; Vivona S Sci Rep; 2021 Jan; 11(1):566. PubMed ID: 33436675 [TBL] [Abstract][Full Text] [Related]
7. Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivity. Webster CI; Hatcher J; Burrell M; Thom G; Thornton P; Gurrell I; Chessell I Pain; 2017 Apr; 158(4):660-668. PubMed ID: 28009628 [TBL] [Abstract][Full Text] [Related]
8. Nanofiber-based delivery of therapeutic peptides to the brain. Mazza M; Notman R; Anwar J; Rodger A; Hicks M; Parkinson G; McCarthy D; Daviter T; Moger J; Garrett N; Mead T; Briggs M; Schätzlein AG; Uchegbu IF ACS Nano; 2013 Feb; 7(2):1016-26. PubMed ID: 23289352 [TBL] [Abstract][Full Text] [Related]
9. Peptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brain. Sarkar G; Curran GL; Sarkaria JN; Lowe VJ; Jenkins RB PLoS One; 2014; 9(5):e97655. PubMed ID: 24847943 [TBL] [Abstract][Full Text] [Related]
10. Discovery of a Highly Conserved Peptide in the Iron Transporter Melanotransferrin that Traverses an Intact Blood Brain Barrier and Localizes in Neural Cells. Singh CSB; Eyford BA; Abraham T; Munro L; Choi KB; Okon M; Vitalis TZ; Gabathuler R; Lu CJ; Pfeifer CG; Tian MM; Jefferies WA Front Neurosci; 2021; 15():596976. PubMed ID: 34149342 [TBL] [Abstract][Full Text] [Related]
11. Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study. Nounou MI; Adkins CE; Rubinchik E; Terrell-Hall TB; Afroz M; Vitalis T; Gabathuler R; Tian MM; Lockman PR Pharm Res; 2016 Dec; 33(12):2930-2942. PubMed ID: 27528392 [TBL] [Abstract][Full Text] [Related]
12. Peptides and Drug Delivery. Ulapane KR; Kopec BM; Moral MEG; Siahaan TJ Adv Exp Med Biol; 2017; 1030():167-184. PubMed ID: 29081054 [TBL] [Abstract][Full Text] [Related]
13. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Pardridge WM Bioconjug Chem; 2008 Jul; 19(7):1327-38. PubMed ID: 18547095 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface. Rolland Y; Demeule M; Fenart L; Béliveau R Pigment Cell Melanoma Res; 2009 Feb; 22(1):86-98. PubMed ID: 19017294 [TBL] [Abstract][Full Text] [Related]
15. A novel peptide delivers plasmids across blood-brain barrier into neuronal cells as a single-component transfer vector. Fu A; Zhang M; Gao F; Xu X; Chen Z PLoS One; 2013; 8(3):e59642. PubMed ID: 23555734 [TBL] [Abstract][Full Text] [Related]
16. Chronic blockade of interleukin-1 (IL-1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury. Gabay E; Wolf G; Shavit Y; Yirmiya R; Tal M Eur J Pain; 2011 Mar; 15(3):242-8. PubMed ID: 20801063 [TBL] [Abstract][Full Text] [Related]
17. Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium. Rothenberger S; Food MR; Gabathuler R; Kennard ML; Yamada T; Yasuhara O; McGeer PL; Jefferies WA Brain Res; 1996 Mar; 712(1):117-21. PubMed ID: 8705293 [TBL] [Abstract][Full Text] [Related]
18. [New protein vectors for physiological transfer of therapeutic agents to the central nervous system]. Gabathuler R Biol Aujourdhui; 2012; 206(3):191-203. PubMed ID: 23171842 [TBL] [Abstract][Full Text] [Related]
19. Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood-brain barrier in rats. Valiante S; Falanga A; Cigliano L; Iachetta G; Busiello RA; La Marca V; Galdiero M; Lombardi A; Galdiero S Int J Nanomedicine; 2015; 10():1885-98. PubMed ID: 25792823 [TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody. Pardridge WM Expert Opin Drug Deliv; 2015 Feb; 12(2):207-22. PubMed ID: 25138991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]